Disruptions in Liver Function among Cancer Patients and Patients Treated with Tyrosine Kinase Inhibiting Drugs: Comparisons of Two Population-Based Databases

Disruptions in Liver Function among Cancer Patients and Patients Treated with Tyrosine Kinase Inhibiting Drugs: Comparisons of Two Population-Based Databases

Liver toxicity is a recognized adverse event associated with small molecule tyrosine kinase inhibitors (TKIs). Electronic Medical Record (EMR) databases offer the most precise data to investigate the rate of liver function test (LFT) elevations; however, they can be limited in sample size and costly...

Full description

Bibliographic Details
Main Authors: Landis, Sarah H., Nordstrom, Beth L., Sansbury, Leah B., Shantakumar, Sumitra, Laurent, Samantha A. St., Fraeman, Kathy H., Nelson, Jeanenne J.
Format: Online
Language:English
Published: Hindawi Publishing Corporation 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654350/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654350/

Similar Items